Formyl-Peptide Receptor 2 Signaling Modulates SLC7A11/xCT Expression and Activity in Tumor Cells

被引:0
|
作者
Cimmino, Tiziana Pecchillo [1 ]
Punziano, Carolina [1 ]
Panico, Iolanda [1 ]
Petrone, Zeudi [1 ]
Cassese, Myrhiam [1 ]
Faraonio, Raffaella [1 ]
Barresi, Vincenza [2 ]
Esposito, Gabriella [1 ]
Ammendola, Rosario [1 ]
Cattaneo, Fabio [1 ]
机构
[1] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy
[2] Univ Catania, Dept Biomed & Biotechnol Sci, I-95123 Catania, Italy
关键词
formyl-peptide receptor 2; NADPH oxidase; glutathione; lipid peroxidation; NRF2; CYSTINE/GLUTAMATE ANTIPORTER; MOLECULAR-MECHANISMS; SYSTEM X(C)(-); NADPH OXIDASES; NOX FAMILY; CANCER; ROS; LOCALIZATION; PEROXIDATION; FERROPTOSIS;
D O I
10.3390/antiox13050552
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer cells exhibit high levels of oxidative stress and consequently require a high amount of cysteine for glutathione synthesis. Solute Carrier Family 7 Member 11 (SLC7A11), or xCT, mediates the cellular uptake of cystine in exchange for intracellular glutamate; imported extracellular cystine is reduced to cysteine in the cytosol through a NADPH-consuming reduction reaction. SLC7A11/xCT expression is under the control of stress-inducing conditions and of several transcription factors, such as NRF2 and ATF4. Formyl-peptide receptor 2 (FPR2) belongs to the FPR family, which transduces chemotactic signals mediating either inflammatory or anti-inflammatory responses according to the nature of its ligands and/or FPR2 binding with other FPR isoforms. The repertoire of FPR2 agonists with anti-inflammatory activities comprises WKYMVm peptide and Annexin A1 (ANXA1), and the downstream effects of the intracellular signaling cascades triggered by FPR2 include NADPH oxidase (NOX)-dependent generation of reactive oxygen species. Herein, we demonstrate that stimulation of CaLu-6 cells with either WKYMVm or ANXA1: (i) induces the redox-regulated activation of SLC7A11/xCT; (ii) promotes the synthesis of glutathione; (iii) prevents lipid peroxidation; and (iv) favors NRF2 nuclear translocation and activation. In conclusion, our overall results demonstrate that FPR2 agonists and NOX modulate SLC7A11/xCT expression and activity, thereby identifying a novel regulative pathway of the cystine/glutamate antiport that represents a new potential therapeutical target for the treatment of human cancers.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Amelioration of nephrotoxicity by targeting ferroptosis: role of NCOA4, IREB2, and SLC7a11 signaling
    Sharawy, N.
    Aboulhoda, B. E.
    Khalifa, M. M.
    Morcos, G. N.
    Morsy, S. A. A. G.
    Alghamdi, M. A.
    Khalifa, I. M.
    Abd Algaleel, W. A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2024, 57
  • [22] SPTBN2 suppresses ferroptosis in NSCLC cells by facilitating SLC7A11 membrane trafficking and localization
    Deng, Jun
    Lin, Xu
    Qin, Jiajia
    Li, Qi
    Zhang, Yingqiong
    Zhang, Qingyi
    Ji, Cong
    Shen, Shuying
    Li, Yangling
    Zhang, Bo
    Lin, Nengming
    REDOX BIOLOGY, 2024, 70
  • [23] Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity
    Cimmino, Tiziana Pecchillo
    Pagano, Ester
    Stornaiuolo, Mariano
    Esposito, Gabriella
    Ammendola, Rosario
    Cattaneo, Fabio
    OPEN BIOLOGY, 2023, 13 (10)
  • [24] Iron Overload Induces Hepatic Ferroptosis and Insulin Resistance by Inhibiting the Jak2/stat3/slc7a11 Signaling Pathway
    Mo, Manqiu
    Pan, Ling
    Deng, Ling
    Liang, Min
    Xia, Ning
    Liang, Yuzhen
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (03) : 2079 - 2094
  • [25] Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1
    Zhang, Yilei
    Koppula, Pranavi
    Gan, Boyi
    CELL CYCLE, 2019, 18 (08) : 773 - 783
  • [26] Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model
    Demuyser, Thomas
    Deneyer, Lauren
    Bentea, Eduard
    Albertini, Giulia
    Femenia, Teresa
    Walrave, Laura
    Sato, Hideyo
    Danbolt, Niels C.
    De Bundel, Dimitri
    Michotte, Alex
    Lindskog, Maria
    Massie, Ann
    Smolders, Ilse
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2019, 20 (05) : 381 - 392
  • [27] Inhibition of SLC7A11 by Sulfasalazine Enhances Osteogenic Differentiation of Mesenchymal Stem Cells by Modulating BMP2/4 Expression and Suppresses Bone Loss in Ovariectomized Mice
    Jin, Chanyuan
    Zhang, Ping
    Zhang, Min
    Zhang, Xiao
    Lv, Longwei
    Liu, Hao
    Liu, Yunsong
    Zhou, Yongsheng
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (03) : 508 - 521
  • [28] Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis
    Wang, Yun
    Chen, Zhe
    Luo, Jing
    Zhang, Jing
    Sang, A-ming
    Cheng, Zhen-shun
    Li, Xin-yi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115
  • [29] Exosomal circBBS2 inhibits ferroptosis by targeting miR-494 to activate SLC7A11 signaling in ischemic stroke
    Hong, Ting
    Zhao, Tingting
    He, Wei
    Xia, Jian
    Huang, Qing
    Yang, Jie
    Gu, Wenping
    Chen, Changqing
    Zhang, Ning
    Liu, Yunhai
    Feng, Jie
    FASEB JOURNAL, 2023, 37 (09)
  • [30] Brazilin Actuates Ferroptosis in Breast Cancer Cells via p53/SLC7A11/GPX4 Signaling Pathway
    He, Dan
    Tan, Xiao-ning
    Li, Lin-pei
    Gao, Wen-hui
    Tian, Xue-fei
    Zeng, Pu-hua
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2024, 30 (11) : 1001 - 1006